TransCode Therapeutics: Invitation to The ThinkEquity Conference Boston, Massachusetts--(Newsfile Corp. - October 19, 2022) -  TransCode Therapeutics  (NASDAQ: RNAZ), the RNA Oncology company committed to more effectively treating cancer using RNA therapeutics, will be participating in The
October 19, 2022|
Displaying 1 - 10 of 23